A Circulating Tumor Cell-RNA Assay for Assessment of Androgen Receptor Signaling Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer

Rationale: Our objective was to develop a circulating tumor cell (CTC)-RNA assay for characterizing clinically relevant RNA signatures for the assessment of androgen receptor signaling inhibitor (ARSI) sensitivity in metastatic castration-resistant prostate cancer (mCRPC) patients. Methods: We devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Jan, Yu Jen, Yoon, Junhee, Chen, Jie-Fu, Teng, Pai-Chi, Yao, Nu, Cheng, Shirley, Lozano, Amber, Chu, Gina C.Y., Chung, Howard, Lu, Yi-Tsung, Chen, Pin-Jung, Wang, Jasmine J., Lee, Yi-Te, Kim, Minhyung, Zhu, Yazhen, Knudsen, Beatrice S., Feng, Felix Y., Garraway, Isla P., Gao, Allen C., Chung, Leland W. K., Freeman, Michael R., You, Sungyong, Tseng, Hsian-Rong, Posadas, Edwin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568173/
https://www.ncbi.nlm.nih.gov/pubmed/31244925
http://dx.doi.org/10.7150/thno.34485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568173/
https://www.ncbi.nlm.nih.gov/pubmed/31244925
http://dx.doi.org/10.7150/thno.34485

Ejemplares similares